Indivior PLC (Nasdaq/LSE: INDV) provides the following update regarding its PDUFA action date for label changes (rapid initiation protocol and alternative injection sites) for SUBLOCADE® ...

The long-time senator said Thursday that RFK Jr. had a "record of trafficking in dangerous conspiracy theories." ...

The ad goes on to tout Hims & Hers' weight loss drugs as less expensive alternatives to medications like Ozempic and Wegovy, ...

The FDA on Tuesday signed off on SpringWorks Therapeutics’ mirdametinib—now to carry the brand name Gomekli—for the treatment ...

Changes to the FDA labeling guidance in support of FALCPA include alterations to the definitions of “major” food allergens ...

Succession actor, Brian Cox, talks to Jonathan Ross about using Ozempic after a whole host of celebrities have started taking ...

The prognostic test stratifies hospitalized women with hypertensive disorders of pregnancy into low- and high-risk categories for developing severe preeclampsia.

Drug industry calls out telehealth company Hims & Hers' Super Bowl ad touting its knock-off weight loss medications.

Reshma Kewalramani, CEO and president of Vertex, called the drug's approval "a historic milestone" in a statement. "We have the opportunity to change the paradigm of acute pain management and ...

A Blair County judge has ruled that statements made to police by a suspect in a drug investigation cannot be used during his upcoming trial because officers did not advise him of his rights to remain ...

Nerandomilast, an oral phosphodiesterase 4B inhibitor, hit the primary endpoint in a Phase III trial in progressive pulmonary ...